Press releases

Press releases

• Ferring and RedHill Biopharma enter strategic partnership for Rebyota® and Clenpiq®

  01 September 2026 - by celia

• Ferring Pharmaceuticals successfully launches its fourth Swiss Franc Bond offering for CHF 250 million

  01 July 2026 - by celia

• Ferring Pharmaceuticals and Gallup announce landmark global public attitudes study on fertility and family-building

  16 April 2026 - by celia

• For the first time, Ferring reports revenue of over €2.5 billion in 2025

  10 March 2026 - by celia

• Ferring announces changes to Board of Directors and Executive Committee

  16 February 2026 - by celia

• Ferring Pharmaceuticals climate targets validated by Science Based Targets initiative

  15 January 2026 - by celia

• With two in five employees undergoing fertility treatment leaving their jobs or considering quitting, are companies doing enough?

  26 November 2025 - by celia

• Ferring Pharmaceuticals to explore strategic options for Rebyota®

  29 October 2025 - by celia

• Ferring Pharmaceuticals announces optimisation of operations to accelerate growth

  07 October 2025 - by celia

• Ferring Japan announces PMDA Acceptance of NDA Filing for nadofaragene firadenovec

  11 September 2025 - by celia